[2-(8,9-ジオキソ-2,6-ジアザビシクロ[5.2.0]ノナ-1(7)-エン-2-イル)アルキル]ホスホン酸の誘導体およびN-メチル-D-アスパルテート(NMDA)受容体アンタゴニストとしてのその使用

Title:

Document Type and Number:

Japanese Patent JP2006523694

Kind Code:

A

Abstract:

Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided where at least one of R2 or R3 is not hydrogen. The compounds of the present invention are N-methyl-D-aspartate (NMDA) receptor antagonists and are useful in treating a variety of conditions present in a mammal that benefit from inhibiting the NMDA receptor.

More Like This:

JP4942915	Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
WO/2002/100860	HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINES, IN PARTICULAR AS ANTI-BACTERIAL AGENTS
JP2010511717	Prodrugs and how to create and use them

Inventors:

Reinhard Bernhard Baudi
John Anthony Butera

Application Number:

JP2006509747A

Publication Date:

October 19, 2006

Filing Date:

April 07, 2004

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Wyeth

International Classes:

C07F9/645; A61K31/675; A61K45/00; A61P3/08; A61P3/10; A61P9/10; A61P11/00; A61P21/00; A61P21/02; A61P25/00; A61P25/04; A61P25/06; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P27/06; A61P29/00; A61P29/02; A61P43/00

Domestic Patent References:

JP2007509055A	2007-04-12
JP2006522834A	2006-10-05
JP2007509055A	2007-04-12
JP2006522834A	2006-10-05

Attorney, Agent or Firm:

Mitsuo Tanaka
Tadayuki Motoyama
Kenji Tomita

Previous Patent: ヒドロキサム酸化合物およびその使用方法

Next Patent: 注射に有用なピペラシリンおよびタゾバクタムを含有する組成物